These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

554 related items for PubMed ID: 15063454

  • 1. Angiotensin-converting enzyme inhibitors, beta-blockers, and mortality in systolic heart failure.
    Thornton PL, Ahmed A.
    J Am Coll Cardiol; 2004 Apr 07; 43(7):1333; author reply 1333-4. PubMed ID: 15063454
    [No Abstract] [Full Text] [Related]

  • 2. A meta-analysis of the effect of angiotensin-converting enzyme inhibitors on functional capacity in patients with symptomatic left ventricular systolic dysfunction.
    Abdulla J, Abildstrom SZ, Christensen E, Kober L, Torp-Pedersen C.
    Eur J Heart Fail; 2004 Dec 07; 6(7):927-35. PubMed ID: 15556055
    [Abstract] [Full Text] [Related]

  • 3. HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction--pharmacological approaches. Heart Failure Society of America.
    Pharmacotherapy; 2000 May 07; 20(5):495-522. PubMed ID: 10809338
    [No Abstract] [Full Text] [Related]

  • 4. Treatments that improve outcome in the patient with heart failure, left ventricular systolic dysfunction, or both after acute myocardial infarction.
    Weir R, McMurray JJ.
    Heart; 2005 May 07; 91 Suppl 2(Suppl 2):ii17-20; discussion ii31, ii43-8. PubMed ID: 15831602
    [Abstract] [Full Text] [Related]

  • 5. "Systolic and diastolic dysfunction" in heart failure? Time for a new paradigm.
    Konstam MA.
    J Card Fail; 2003 Feb 07; 9(1):1-3. PubMed ID: 12612866
    [No Abstract] [Full Text] [Related]

  • 6. [Diastolic cardiac insufficiency].
    Spoto S, Palma Modoni A, De Galasso L.
    Clin Ter; 2002 Feb 07; 153(5):355-7. PubMed ID: 12510423
    [No Abstract] [Full Text] [Related]

  • 7. Applying standard therapies to new targets: the use of ACE inhibitors and B-blockers for heart failure in adults with congenital heart disease.
    Vonder Muhll I, Liu P, Webb G.
    Int J Cardiol; 2004 Dec 07; 97 Suppl 1():25-33. PubMed ID: 15590076
    [Abstract] [Full Text] [Related]

  • 8. From left ventricular dysfunction to heart failure.
    Cleland JG.
    Arch Mal Coeur Vaiss; 1996 Nov 07; 89(11):1397-402. PubMed ID: 9092398
    [Abstract] [Full Text] [Related]

  • 9. [Treatment of heart failure and preserved systolic function].
    Dahlström U, Boman K, Brodin LA, Hagerman I, Willenheimer R.
    Lakartidningen; 1996 Nov 07; 104(34):2348-50. PubMed ID: 17907560
    [No Abstract] [Full Text] [Related]

  • 10. Sudden cardiac death after heart failure; symptomatic versus disease treatment? An editorial comment.
    Buckberg GD, RESTORE team.
    Heart Fail Rev; 2004 Oct 07; 9(4):347-51. PubMed ID: 15886980
    [No Abstract] [Full Text] [Related]

  • 11. Managing patients with heart failure: the reality of clinical practice.
    Squire I.
    Eur Heart J; 2005 Dec 07; 26(24):2611-3. PubMed ID: 16219652
    [No Abstract] [Full Text] [Related]

  • 12. Remodeling in systolic heart failure: therapeutic implications.
    Chatterjee K.
    Indian Heart J; 2004 Dec 07; 56(2):99-109. PubMed ID: 15377130
    [No Abstract] [Full Text] [Related]

  • 13. [Chronic left heart failure. A focus on the pathogenetic basis of medical treatment].
    Novosel MK, Haghfelt TH.
    Ugeskr Laeger; 2006 May 08; 168(19):1854-6. PubMed ID: 16756801
    [Abstract] [Full Text] [Related]

  • 14. Should beta-blockers form the cornerstone for the treatment of congestive heart failure?
    Tabrizchi R.
    Expert Rev Cardiovasc Ther; 2003 Jul 08; 1(2):157-60. PubMed ID: 15030275
    [No Abstract] [Full Text] [Related]

  • 15. ACE inhibitors and beta blockers in chronic congestive cardiac failure: therapeutic basis.
    Manoria PC, Manoria P.
    J Indian Med Assoc; 2003 May 08; 101(5):311-2, 315. PubMed ID: 14575221
    [Abstract] [Full Text] [Related]

  • 16. Guideline for the management of heart failure caused by systolic dysfunction: part II. Treatment.
    Chavey WE, Blaum CS, Bleske BE, Harrison RV, Kesterson S, Nicklas JM, American Heart Association.
    Am Fam Physician; 2001 Sep 15; 64(6):1045-54. PubMed ID: 11578026
    [Abstract] [Full Text] [Related]

  • 17. Role of neurohormonal modulators in heart failure with relatively preserved systolic function.
    Rapp JA, Gheorghiade M.
    Heart Fail Clin; 2005 Apr 15; 1(1):77-93. PubMed ID: 17386836
    [No Abstract] [Full Text] [Related]

  • 18. Heart Failure Society of America (HFSA) practice guidelines. HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction--pharmacological approaches.
    J Card Fail; 1999 Dec 15; 5(4):357-82. PubMed ID: 10634677
    [No Abstract] [Full Text] [Related]

  • 19. Heart failure survival score in patients with Chagas disease: correlation with functional variables.
    Ritt LE, Carvalho AC, Feitosa GS, Pinho-Filho JA, Macedo CR, Vilas-Boas F, Andrade MV, Feitosa-Filho GS, Almeida AJ, Barojas M, Lopes RD.
    Rev Esp Cardiol (Engl Ed); 2012 Jun 15; 65(6):538-43. PubMed ID: 22513344
    [Abstract] [Full Text] [Related]

  • 20. Heart failure: recent advances in prevention and treatment.
    Fonarow GC.
    Rev Cardiovasc Med; 2000 Jun 15; 1(1):25-33, 54. PubMed ID: 12457149
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.